MedCity News March 29, 2020
Elise Reuter

Venture capital firms are making fewer investments as the Covid-19 pandemic surges in the U.S. But many still say they are still open for business.

A surprising number of venture capital firms said they’re still open for business, in spite of the Covid-19 pandemic. But deal-making has slowed substantially, as companies try weigh what will be needed to survive the coming months. How you invest in the midst of a health crisis that has left a third of the U.S. population stuck at home, and with many businesses struggling for cash?

MedCity News interviewed venture capital firms focused on digital health, biotechnology and medtech by phone and by email. Six investors shared their strategies for weathering this storm, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Investments, Technology, Trends
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Zephyr AI Raises $111 Million in Series A Financing
Private equity pushes wave of healthcare bankruptcies
What 2024 Valley titans want (and get wrong)

Share This Article